FindTrial
Sign In

SERUM C PEPTIDE LEVELS AND ITS ASSOCIATION WITH CHRONIC VASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

SERUM C PEPTIDE LEVELS AND CHRONIC VASCULAR COMPLICATIONS IN TYPE 2 DIABETES MELLITUS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050714
Enrollment
147
Registered
2023-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

SELF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus patients of both sex with ages more than 35 years with a duration of diabetes of more than 5 years and less than 15 years

Exclusion criteria

Exclusion criteria: 1. Type 2 diabetic patients on insulin treatment 2. All patients with secondary diabetes and those on steroid therapy. 3. Pregnant and lactating females. 4. Patients with active infections like pneumonia, sepsis and critical illness. 5. Patients with chronic liver disease, acute hepatitis and malignancy. 6. Patients with renal impairment with GFR less than 45ml/min/1.73m2

Design outcomes

Primary

MeasureTime frame
Chronic Microvascular Complications- Diabetic Retinopathy, Diabetic Neuropathy and Diabetic Nephropathy. Chronic Macrovascular Complications- Coronary Artery disease,Cerebro vascular disease and Peripheral Artery diseaseTimepoint: At baseline.—

Secondary

MeasureTime frame
Chronic Macrovascular Complications- Coronary Artery disease,Cerebro vascular disease and Peripheral Artery diseaseTimepoint: At baseline itself.—

Countries

India

Contacts

Public ContactDr SAROSH KUMAR K K

Government Medical College Kannur

kksarosh@yahoo.com04972808111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026